Baicalein suppresses 17-β-estradiol-induced migration, adhesion and invasion of breast cancer cells via the G protein-coupled receptor 30 signaling pathway

Oncology Reports

Volumn 33, Issue 4, 2015, Pages 2077-2085

  Shang, Dandan ^a   Li, Zheng ^a   Zhu, Zhuxia ^a   Chen, Huamei ^a   Zhao, Lujun ^a   Wang, Xudong ^a   Chen, Yan ^a  

^a GUIZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Adhesion; Baicalein; Breast cancer; Estrogen; G protein coupled receptor 30; Invasion; Migration

Indexed keywords

BAICALEIN; CONNECTIVE TISSUE GROWTH FACTOR; CYSTEINE RICH PROTEIN 61; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTRADIOL; G PROTEIN COUPLED RECEPTOR 30; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; CTGF PROTEIN, HUMAN; CYR61 PROTEIN, HUMAN; EGFR PROTEIN, HUMAN; ESTROGEN RECEPTOR; FLAVANONE DERIVATIVE; G PROTEIN COUPLED RECEPTOR; GPER PROTEIN, HUMAN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL LINE; CANCER INHIBITION; CELL ADHESION; CTGF GENE; CYR61 GENE; GENE EXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; MCF 7 CELL LINE; MIGRATION INHIBITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SK BR 3 CELL LINE; TUMOR INVASION; UPREGULATION; WOUND HEALING; BREAST NEOPLASMS; CELL MOTION; DRUG EFFECTS; FEMALE; GENETICS; PHOSPHORYLATION; TUMOR CELL LINE;

BREAST NEOPLASMS; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CONNECTIVE TISSUE GROWTH FACTOR; CYSTEINE-RICH PROTEIN 61; ESTRADIOL; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; FLAVANONES; HUMANS; MCF-7 CELLS; NEOPLASM INVASIVENESS; PHOSPHORYLATION; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, ESTROGEN; RECEPTORS, G-PROTEIN-COUPLED; RNA, MESSENGER; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 84924860075     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2015.3786     Document Type: Article

References (40)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
2. Libson S and Lippman M: A review of clinical aspects of breast cancer. Int Rev Psychiatry 26: 4-15, 2014.
3. Yager JD and Davidson NE: Estrogen carcinogenesis in breast cancer. N Engl J Med 354: 270-282, 2006.
4. Planey SL, Kumar R and Arnott JA: Estrogen receptors (ER? versus ER?): friends or foes in human biology. J Recept Signal Transduct Res 34: 1-5, 2014.
5. Herynk MH and Fuqua SA: Estrogen receptors in resistance to hormone therapy. Adv Exp Med Biol 608: 130-143, 2007.
6. Prossnitz ER and Maggiolini M: Mechanisms of estrogen signaling and gene expression via GPR30. Mol Cell Endocrinol 308: 32-38, 2009.
7. Maggiolini M and Picard D: The unfolding stories of GPR30, a new membrane-bound estrogen receptor. J Endocrinol 204: 105-114, 2010.
8. Filardo EJ, Graeber CT, Quinn JA, Resnick MB, Giri D, DeLellis RA, Steinhoff MM and Sabo E: Distribution of GPR30, a seven membrane-spanning estrogen receptor, in primary breast cancer and its association with clinicopathologic determinants of tumor progression. Clin Cancer Res 12: 6359-6366, 2006.
9. Berger CE, Qian Y, Liu G, Chen H and Chen X: p53, a target of estrogen receptor (ER) ?, modulates DNA damage-induced growth suppression in ER-positive breast cancer cells. J Biol Chem 287: 30117-30127, 2012.
10. Liu Q, Li JG, Zheng XY, Jin F and Dong HT: Expression of CD133, PAX2, ESA, and GPR30 in invasive ductal breast carcinomas. Chin Med J (Engl) 122: 2763-2769, 2009.
11. Takemura H, Sakakibara H, Yamazaki S and Shimoi K: Breast cancer and flavonoids-A role in prevention. Curr Pharm Des 19: 6125-6132, 2013.
12. Rosenberg Zand RS, Jenkins DJ and Diamandis EP: Flavonoids and steroid hormone-dependent cancers. J Chromatogr B Analyt Technol Biomed Life Sci 777: 219-232, 2002.
13. Srinivas NR: Baicalin, an emerging multi-therapeutic agent: pharmacodynamics, pharmacokinetics, and considerations from drug development perspectives. Xenobiotica 40: 357-367, 2010.
14. Po LS, Chen ZY, Tsang DS and Leung LK: Baicalein and genistein display differential actions on estrogen receptor (ER) transactivation and apoptosis in MCF-7 cells. Cancer Lett 187: 33-40, 2002.
15. Shenouda NS, Zhou C, Browning JD, Ansell PJ, Sakla MS, Lubahn DB and Macdonald RS: Phytoestrogens in common herbs regulate prostate cancer cell growth in vitro. Nutr Cancer 49: 200-208, 2004.
16. Lin CW, Yang LY, Shen SC and Chen YC: IGF-I plus E2 induces proliferation via activation of ROS-dependent ERKs and JNKs in human breast carcinoma cells. J Cell Physiol 212: 666-674, 2007.
17. Li Y, Wang JP, Santen RJ, Kim TH, Park H, Fan P and Yue W: Estrogen stimulation of cell migration involves multiple signaling pathway interactions. Endocrinology 151: 5146-5156, 2010.
18. Qi Q, Lu N, Wang XT, Gu HY, Yang Y, Liu W, Li C, You QD and Guo QL: Anti-invasive effect of gambogic acid in MDA-MB-231 human breast carcinoma cells. Biochem Cell Biol 86: 386-395, 2008.
19. Chen P, Lu N, Ling Y, Chen Y, Hui H, Lu Z, Song X, Li Z, You Q and Guo Q: Inhibitory effects of wogonin on the invasion of human breast carcinoma cells by downregulating the expression and activity of matrix metalloproteinase-9. Toxicology 282: 122-128, 2011.
20. Xie D, Nakachi K, Wang H, Elashoff R and Koeffler HP: Elevated levels of connective tissue growth factor, WISP-1, and CYR61 in primary breast cancers associated with more advanced features. Cancer Res 61: 8917-8923, 2001.
21. Pupo M, Pisano A, Lappano R, Santolla MF, De Francesco EM, Abonante S, Rosano C and Maggiolini M: Bisphenol A induces gene expression changes and proliferative effects through GPER in breast cancer cells and cancer-associated fibroblasts. Environ Health Perspect 120: 1177-1182, 2012.
22. Ferreira E and Cronjé MJ: Selection of suitable reference genes for quantitative real-time PCR in apoptosis-induced MCF-7 breast cancer cells. Mol Biotechnol 50: 121-128, 2012.
23. Filardo EJ, Quinn JA and Sabo E: Association of the membrane estrogen receptor, GPR30, with breast tumor metastasis and transactivation of the epidermal growth factor receptor. Steroids 73: 870-873, 2008.
24. Filardo EJ, Quinn JA, Bland KI and Frackelton AR Jr.: Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. Mol Endocrinol 14: 1649-1660, 2000.
25. Ge C, Yu M and Zhang C: G protein-coupled receptor 30 mediates estrogen-induced proliferation of primordial germ cells via EGFR/Akt/?-catenin signaling pathway. Endocrinology 153: 3504-3516, 2012.
26. Pandey DP, Lappano R, Albanito L, Madeo A, Maggiolini M and Picard D: Estrogenic GPR30 signalling induces proliferation and migration of breast cancer cells through CTGF. EMBO J 28: 523-532, 2009.
27. Stingl J: Estrogen and progesterone in normal mammary gland development and in cancer. Horm Cancer 2: 85-90, 2011.
28. Haldosén LA, Zhao C and Dahlman-Wright K: Estrogen receptor beta in breast cancer. Mol Cell Endocrinol 382: 665-672, 2014.
29. Ganapathy V, Banach-Petrosky W, Xie W, Kareddula A, Nienhuis H, Miles G and Reiss M: Luminal breast cancer metastasis is dependent on estrogen signaling. Clin Exp Metastasis 29: 493-509, 2012.
30. Zheng S, Huang J, Zhou K, Zhang C, Xiang Q, Tan Z, Wang T and Fu X: 17?-estradiol enhances breast cancer cell motility and invasion via extra-nuclear activation of actin-binding protein ezrin. PLoS One 6: e22439, 2011.
31. Perlikos F, Harrington KJ and Syrigos KN: Key molecular mechanisms in lung cancer invasion and metastasis: a comprehensive review. Crit Rev Oncol Hematol 87: 1-11, 2013.
32. Yu T, Liu M, Luo H, Wu C, Tang X, Tang S, Hu P, Yan Y, Wang Z and Tu G: GPER mediates enhanced cell viability and motility via non-genomic signaling induced by 17?-estradiol in triple?negative breast cancer cells. J Steroid Biochem Mol Biol 143: 392-403, 2014.
33. Jiang QF, Wu TT, Yang JY, Dong CR, Wang N, Liu XH and Liu ZM: 17?-estradiol promotes the invasion and migration of nuclear estrogen receptor-negative breast cancer cells through cross-talk between GPER1 and CXCR1. J Steroid Biochem Mol Biol 138: 314-324, 2013.
34. Chen Y, Li Z, He Y, Shang D, Pan J, Wang H, Chen H, Zhu Z, Wan L and Wang X: Estrogen and pure antiestrogen fulvestrant (ICI 182 780) augment cell-matrigel adhesion of MCF-7 breast cancer cells through a novel G protein coupled estrogen receptor (GPR30)-to-calpain signaling axis. Toxicol Appl Pharmacol 275: 176-181, 2014.
35. Li Y, Chen Y, Zhu ZX, Liu XH, Yang L, Wan L, Lei TW and Wang XD: 4-Hydroxytamoxifen-stimulated processing of cyclin E is mediated via G protein-coupled receptor 30 (GPR30) and accompanied by enhanced migration in MCF-7 breast cancer cells. Toxicology 309: 61-65, 2013.
36. Jun JI and Lau LF: Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets. Nat Rev Drug Discov 10: 945-963, 2011.
37. Espinoza I, Liu H, Busby R and Lupu R: CCN1, a candidate target for zoledronic acid treatment in breast cancer. Mol Cancer Ther 10: 732-741, 2011.
38. Chen PS, Wang MY, Wu SN, et al: CTGF enhances the motility of breast cancer cells via an integrin-alphavbeta3?ERK1/2?dependent S100A4-upregulated pathway. J Cell Sci 120: 2053-2065, 2007.
39. Maggiolini M, Vivacqua A, Fasanella G, Recchia AG, Sisci D, Pezzi V, Montanaro D, Musti AM, Picard D and Andó S: The G protein-coupled receptor GPR30 mediates c-fos up-regulation by 17beta-estradiol and phytoestrogens in breast cancer cells. J Biol Chem 279: 27008-27016, 2004.
40. Vivacqua A, Bonofiglio D, Albanito L, Madeo A, Rago V, Carpino A, Musti AM, Picard D, Andó S and Maggiolini M: 17beta-estradiol, genistein, and 4-hydroxytamoxifen induce the proliferation of thyroid cancer cells through the g protein?coupled receptor GPR30. Mol Pharmacol 70: 1414-1423, 2006.